Explainable machine learning framework for biomarker discovery by combining biological age and frailty prediction (Preprint)

Author:

Wang XihengORCID,Ji JieORCID

Abstract

BACKGROUND

Biological age (BA) and frailty represent two distinct health measures that offer valuable insights into the aging process. Existing machine learning (ML) predictors of BA and frailty, derived from blood-based biomarkers, lack the capability to compare and analyze these biomarkers comprehensively. Such comparisons may provide deeper insights into these two distinct aging pathways. Objective: This study aimed to develop a framework to compare and analyze biomarkers by combining BA and frailty ML predictors with eXplainable Artificial Intelligence (XAI) techniques.

OBJECTIVE

This study aimed to develop a framework to compare and analyze biomarkers by combining BA and frailty ML predictors with eXplainable Artificial Intelligence (XAI) techniques.

METHODS

We utilized data from middle-aged and older Chinese adults (≥45 years) in the 2011/2012 wave (n=9702) and the 2015/2016 wave (n=9455, as test set validation) of the China Health and Retirement Longitudinal Study (CHARLS). Sixteen blood-based biomarkers were used to predict BA and frailty. Four tree-based ML algorithms were employed in the training and validation, and performance metrics were compared to select the best models. Then, SHapley Additive exPlanations (SHAP) analysis was conducted on the selected models.

RESULTS

CatBoost performed the best in the BA predictor, and Gradient Boosting performed the best in the frailty predictor. Traditional ML feature importance identified cystatin C and glycated hemoglobin as the major contributors for their respective models. However, subsequent SHAP analysis demonstrated that only cystatin C was the primary contributor in both models, suggesting that it plays an important role in both pathways.

CONCLUSIONS

Our novel framework integrates BA and frailty predictors with XAI techniques to compare and analyze biomarkers. The present approach leverages routine blood biomarkers and can easily incorporate additional biomarkers, providing a scalable and comprehensive toolset that offers a quantitative understanding of interesting biomarkers and complex physiological traits.

CLINICALTRIAL

Publisher

JMIR Publications Inc.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3